Loading clinical trials...
Loading clinical trials...
Study of the Cardio Renal Effects of SGLT2 Inhibitors Among Diabetic and Non-diabetic Lupus Nephritis Patients
Conditions
Interventions
dapagliflozin
placebo
Locations
1
Egypt
Urology and Nephrology Center
Al Mansurah, Egypt
Start Date
October 1, 2022
Primary Completion Date
January 1, 2024
Completion Date
January 1, 2024
Last Updated
April 16, 2025
NCT07315516
NCT07376343
NCT07420205
NCT05393830
NCT07515534
NCT07313293
Lead Sponsor
Mansoura University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions